財務情報
- Market Capitalization 622.34 M
- Employee 61
- Founded 2006
- CEO N/A
- Website www.zevra.com
- Headquarter Delaware, United States
- FIGI BBG0026ZG1F5
- Industry 生物工学
総売上高
当期純利益
1株当たり基本利益(基本EPS)
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
6.64
売上高対価格比率
4.82
関連ティッカー
| # | 名前 | 価格 | 24時間% | 7日% | 1か月% | 1年% | 時価総額 | 過去7日 | |
|---|---|---|---|---|---|---|---|---|---|
| 2680 | AVTX Avalo Therapeutics, Inc. - Common Stock | 11.75 USD | -2.16% | -14.36% | -27.15% | -16.01% | 630.15 M USD | ||
| 2696 | IMMX Immix Biopharma, Inc. - Common Stock | 8.55 USD | -1.61% | -9.33% | -31.55% | +244.76% | 611.66 M USD | ||
| 2707 | DSGN Design Therapeutics, Inc. - Common Stock | 9.76 USD | -0.20% | -17.78% | -27.54% | +46.11% | 610.80 M USD | ||
| 2712 | OLMA Olema Pharmaceuticals, Inc. - Common Stock | 6.79 USD | -3.28% | -15.86% | -34.01% | -17.09% | 594.11 M USD |